Achema middle east

Agility Receives WDA(H) Authorisation for Pharmaceuticals

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Cold Chain and Temperature-Controlled Laboratory Equipment in Pharmaceutical Research and Development

Temperature-sensitive biologics, advanced therapeutics, and pharmaceutical research materials demand specialized cold storage infrastructure spanning ultra-low temperature freezers, controlled-rate freezing systems, and validated stability chambers that maintain precise thermal conditions throughout research, development and testing workflows.

Bringing Seamlessness to the Pharmaceutical Supply Chain

It is well to be noted that freight audits,...

Future-Proofing Pharma Supply Chains: Strategies and Technologies

In light of the post-pandemic future of healthcare, it...
- Advertisement -

Agility, a leading global logistics provider, has received a Wholesaler Distribution Authorisation (for Medicines for Human Use) from the UK Medicines Healthcare & Regulatory Agency (MHRA).

The certification, referred to as WDA(H), authorizes warehousing and cross-dock of a wide range of pharmaceuticals, including finished products and active pharmaceutical ingredients (API) under ambient and cold chain conditions.

The certification covers the Agility-managed pharma storage facility at London’s Heathrow Airport and a second pharma competence centre in Bristol. The WDA(H) allows Agility  to provide a number of additional services, including pick-and-pack operations for the distribution of stored products to hospitals, pharmacies and other distributors, the re-packing into active and passive shipping configurations, and the distribution of clinical trial materials.

Colm McAlinden, Managing Director for Agility Area North West, said, “With this new certification, we are able to expand our Life Science service offerings in the UK and operate on behalf of our customers, particularly virtual wholesalers, brokers and importers. The certification also provides Agility with flexibility for post-Brexit import and export regulations.”

In the UK, Agility also provides logistics services to the aerospace, automotive, hi-tech, and retail industries. Agility offers more than 27,000 sqm of open and bonded warehouse space across 17 locations, including temperature-controlled storage. Agility’s combination of local service and global resources has helped it establish relationships spanning 15 to 20 years with many customers in the country.

About Agility
Agility brings efficiency to supply chains in some of the globe’s most challenging environments, offering unmatched personal service, a global footprint and customized capabilities in developed and developing economies alike. Agility is one of the world’s leading providers of integrated logistics. It is a publicly traded company with more than $4.6 billion in revenue and more than 22,000 employees in over 500 offices across 100 countries. Agility’s core commercial business, Global Integrated Logistics (GIL), provides supply chain solutions to meet traditional and complex customer needs. GIL offers air, ocean and road freight forwarding, warehousing, distribution, and specialized services in project logistics, fairs and events, and chemicals. Agility’s Infrastructure group of companies manages industrial real estate and offers logistics-related services, including e-government customs optimization and consulting, waste management and recycling, aviation and ground-handling services, support to governments and ministries of defense, remote infrastructure and life support. For more information about Agility, visit agility.com

Latest stories

Related stories

Cold Chain and Temperature-Controlled Laboratory Equipment in Pharmaceutical Research and Development

Temperature-sensitive biologics, advanced therapeutics, and pharmaceutical research materials demand specialized cold storage infrastructure spanning ultra-low temperature freezers, controlled-rate freezing systems, and validated stability chambers that maintain precise thermal conditions throughout research, development and testing workflows.

Bringing Seamlessness to the Pharmaceutical Supply Chain

It is well to be noted that freight audits,...

Future-Proofing Pharma Supply Chains: Strategies and Technologies

In light of the post-pandemic future of healthcare, it...

Innovative Solutions for Pharma Supply Chain Efficiency

4.4% of all greenhouse gas emissions come from the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »